Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007;186(1):70-7.
doi: 10.1159/000102682.

Disorders of human dentin

Affiliations

Disorders of human dentin

P Suzanne Hart et al. Cells Tissues Organs. 2007.

Abstract

Dentin, the most abundant tissue in teeth, is produced by odontoblasts, which differentiate from mesenchymal cells of the dental papilla. Dentinogenesis is a highly controlled process that results in the conversion of unmineralized predentin to mineralized dentin. By weight, 70% of the dentin matrix is mineralized, while the organic phase accounts for 20% and water constitutes the remaining 10%. Type I collagen is the primary component (>85%) of the organic portion of dentin. The non-collagenous part of the organic matrix is composed of various proteins, with dentin phosphoprotein predominating, accounting for about 50% of the non-collagenous part. Dentin defects are broadly classified into two major types: dentinogenesis imperfectas (DIs, types I-III) and dentin dysplasias (DDs, types I and II). To date, mutations in DSPP have been found to underlie the dentin disorders DI types II and III and DD type II. With the elucidation of the underlying genetic mechanisms has come the realization that the clinical characteristics associated with DSPP mutations appear to represent a continuum of phenotypes. Thus, these disorders should likely be called DSPP-associated dentin defects, with DD type II representing the mild end of the phenotypic spectrum and DI type III representing the severe end.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Clinical and radiographic features of DI types I–III (a–g) and DD types I and II (h–j). a–c Individuals with DI type I. In this family, affected members also had OI type I due to a missense alteration in COL1A1 (p.Gly559Cys). a, b The constriction of the crown in the cervical region and almost complete obliteration of the pulp chambers. c The enamel has fractured from the central and lateral incisors, exposing the underlying yellow-brown dentin. d, e An individual with DI type II. f, g An affected male from the Brandywine cohort. h The extremely short roots characteristic of DD type I. i The phenotype in deciduous teeth that resembles DI type II, but the permanent teeth are normal in color. j The thistle-tube deformity commonly seen in DD type II.
Fig. 2
Fig. 2
Diagram of the DSPP gene and corresponding protein structure. Mutations are shown above the ge-nomic structure. Gray areas correspond to untranslated regions. The white box corresponds to the signal peptide [amino acids (aa) 1–15]. DSP is shown as black regions (aa 16–382). DGP, represented by a stippled box, corresponds to aa 383–462. The highly repetitive protein, DPP, is shown as a striped box (aa 463–1253).

References

    1. Consortium ADHR. Autosomal dominant hypophosphatemic rickets is associated with mutations in FGF23. Nat Genet. 2000;26:345–348. - PubMed
    1. Alvares K, Kanwar YS, Veis A. Expression and potential role of dentin phosphophoryn (DPP) in mouse embryonic tissues involved in epithelial-mesenchymal interactions and branching morphogenesis. Dev Dyn. 2006;235:2980–2990. - PubMed
    1. Arana-Chavez VE, Massa LF. Odontoblasts: the cells forming and maintaining dentine. Int J Biochem Cell Biol. 2004;36:1367–1373. - PubMed
    1. Beattie ML, Kim J-W, Gong S-G, Murdoch-Kinch CA, Simmer JP, Hu JC-C. Phenotypic variation in dentinogenesis imperfecta/dentin dysplasia linked to 4q21. J Dent Res. 2006;85:329–333. - PMC - PubMed
    1. Benet-Pagès A, Orlik P, Strom TM, Lorenz-Depiereux B. An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia. Hum Mol Genet. 2005;14:385–390. - PubMed

Publication types

Substances